Screener
Rein Therapeutics Inc. RNTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$5.84M-6.1% | -$31.97M+22.0% | -$5.58M+4.5% | -$6.82M+23.7% | -$5.5M+22.7% | ||
| —— | —— | —— | $1K-75.0% | $0-100% | ||
| $156K-40.9% | $257K+93.2% | $1.45M+185% | $256K-21.5% | $264K+76.0% | ||
| -$3.42M+44.6% | -$3.22M+33.1% | -$3.55M+7.1% | -$6.42M+23.5% | -$6.18M-17.2% | ||
| —— | —— | —— | —— | —— | ||
| $4.65M+531% | $2.41M+240,400% | $1.9M— | $4.71M-74.2% | $738K— | ||
| $1.23M+123% | -$833K+82.7% | -$1.67M+60.8% | -$1.71M-117% | -$5.44M-3.1% |
FAQ
- How much cash does Rein Therapeutics Inc. generate?
- Rein Therapeutics Inc. (RNTX) generated -$16.6M in operating cash flow over the trailing twelve months.
- Where does Rein Therapeutics Inc.'s cash flow data come from?
- Every line is extracted from Rein Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.